Breakthrough $20 million OCT project aims to revolutionize eye health screening

In the United States, more than one-fourth of adults over age 40 have an eye disease, including glaucoma, cataracts or age-related macular degeneration, or a chronic health condition that affects the eyes, such as diabetic retinopathy.

Nanoparticles turbocharge turmeric’s curcumin for enhanced health benefits

Study explores nanoparticle-enhanced curcumin formulations, promising to significantly boost its health benefits including anticancer, antioxidant, and anti-inflammatory effects by improving bioavailability and bioactivity.

March 18, 2024

Novo Nordisk’s oral semaglutide on par with injectable version in weight loss and safety

An oral version of Novo Nordisk’s semaglutide helped patients taking the highest dose lose 15% of their body weight. It’s on par with Novo’s Wegovy,

June 26, 2023

Unborn baby ‘remote controls’ mother’s metabolism using ‘greedy’ gene inherited from dad

Fetuses use a copy of a gene inherited from their dad to force their mum to release as much nutrients as possible during pregnancy, Cambridge

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.